Dr. Kaufman is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Connect with other colleagues in the same hospital or clinic
- Search all U.S. specialist profiles and refer a patient
- Read the latest clinical news and earn CME/CEU credits
Office
9500 GILMAN DR.
MC 0695, Sanford Consortium
La Jolla, CA 92093Phone+1 858-822-1777- Is this information wrong?
Education & Training
University of Wisconsin Hospitals and ClinicsFellowship, Hematology and Medical Oncology, 1999 - 2002- University of Wisconsin Hospitals and ClinicsResidency, Internal Medicine, 1996 - 1999
Mayo Clinic College of MedicineClass of 1996
Certifications & Licensure
CA State Medical License 2016 - 2025
MN State Medical License 2002 - 2016
WI State Medical License 1997 - 2003- American Board of Internal Medicine Hematology
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2012-2013
- Elected Member The American Society for Clinical Investigation, 2009
Publications & Presentations
PubMed
- 1 citationsMetastatic gastric cancer target lesion complete response with Claudin18.2-CAR T cells.Botta, G., Chao, J., Ma, H., Hahn, M., Sierra, G., Jia, J., Hendrix, A., Nolte Fong, J., Ween, A., Vu, P., Miller, A., Choi, M., Heyman, B., Daniels, G., Kaufman, D., ...> ;Journal for Immunotherapy of Cancer. 2024 Feb 5
- 13 citationsCHMP2A regulates tumor sensitivity to natural killer cell-mediated cytotoxicity.Davide Bernareggi, Qi Xie, Briana C Prager, Jiyoung Yun, Luisjesus S Cruz, Timothy V Pham, William Kim, Xiqing Lee, Michael Coffey, Cristina Zalfa, Pardis Azmoon, Huan...> ;Nature Communications. 2022 Apr 7
- 4 citationsInto the multiverse of gene edited NK cell-based therapeutic strategies.Benjamin H. Goldenson, Dan S. Kaufman> ;Cell Stem Cell. 2021 Dec 2
- Join now to see all
Abstracts/Posters
- FT596: Translation of First-of-Kind Multi-Antigen Targeted Off-the-Shelf CAR-NK Cell with Engineered Persistence for the Treatment of B Cell MalignanciesDan S Kaufman, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/7/2019
- FT538: Preclinical Development of an Off-the-Shelf Adoptive NK Cell Immunotherapy with Targeted Disruption of CD38 to Prevent Anti-CD38 Antibody-Mediated Fratricide an...Dan S Kaufman, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/7/2019
- Deletion of CISH in Human Pluripotent Stem Cell-Derived Natural Killer Cells Enhances Anti-Tumor Activity Via Metabolic ReprogrammingDan S Kaufman, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019
- Join now to see all
Press Mentions
State Stem Cell Agency Funds Three New UC San Diego ProjectsAugust 25th, 2021
Arming Immune Foot Soldiers Against CancerMay 13th, 2020
Cancer: 'Off-the-Shelf' Stem Cell Treatment Enters Clinical TrialDecember 2nd, 2019- Join now to see all
Grant Support
- Stem Cell Therapy For Myocardial RepairNational Heart, Lung, And Blood Institute2011–2012
- Osteogenic Repair From Human Pluripotent Stem CellsNational Institute Of Dental &Craniofacial Research2011
- Stem Cell Biology Training ProgramEunice Kennedy Shriver National Institute Of Child Health &Human Development2010–2011
- Midwestern Progenitor Cell ConsortiumNational Heart, Lung, And Blood Institute2009–2011
- Hematopoietic Precursor Development From Human Embryonic Stem (ES) CellsNational Heart, Lung, And Blood Institute2007–2010
- Hematopoietic Precursor Development From Human ES CellsNational Heart, Lung, And Blood Institute2006
- Immunocompromised Mouse CoreNational Cancer Institute2005
- In Vivo Potential Of Human ES Cell-Derived Blood CellsNational Heart, Lung, And Blood Institute2002–2004
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
